Colorectal cancer screening cuts death risk 43%: study
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Karolinska Institutet and Umeå University researchers reported that people who participated in colorectal cancer screening had a 43% lower risk of dying from the disease, based on data from 376,511 people followed for up to 14 years.
- The study, published in JAMA Network Open, drew on Sweden's Stockholm-Gotland screening program, which has offered routine biennial screening to people aged 60–74 since 2008 using a take-home fecal occult blood test.
- Johannes Blom, the study's corresponding author and a senior consultant at Karolinska Institutet, said receiving an invitation alone was tied to a 26% lower mortality risk — but actual participation pushed the figure to 43%, far above the 14% reduction found in earlier evaluations.
- Despite the test being free and simple — a stool sample checked for blood invisible to the naked eye, followed by a colonoscopy if positive — roughly one-third of invited people do not submit a sample, according to Blom.
- During the follow-up period, researchers recorded 1,668 colorectal cancer deaths among the 376,511 participants; the study was funded by the Swedish Cancer Society, the Swedish Research Council, and Region Stockholm.
- The researchers flagged that the mortality estimates depend on statistical adjustments to correct for nonadherence and contamination bias, leaving some residual uncertainty in the figures.
Why it matters: For the roughly one-third of invited people who never submit a stool sample despite free testing, this study puts a number on what's lost: participation drove a 43% mortality reduction versus 26% for just receiving an invitation — a 17-point gap that turns screening outreach from a public-health nicety into a measurable survival lever, and shifts the policy focus from expanding eligibility to closing the participation gap.
Ask SkimNews
